Zdrowie i gospodarka · 15/03/2017
FDA Extends Comment Period for Interchangeability Guidance
The Food and Drug Administration is extending the comment period for its January 18, 2017 notice on demonstrating interchangeability with a reference product, in response to requests for an extension from interested persons.
Source: Federal Register — Food and Drug AdministrationOpen original release →